Roivant Sciences
Building a 0 to 1 platform for AI-powered drug discovery
product design, design systems, marketing website
Services
Website
https://www.vant.ai/Background
VantAI is a groundbreaking platform that expedites the development of life-altering drugs for previously incurable diseases and specific cancers. We collaborated with Roivant to jointly conceptualize and this AI-powered workflow management platform tailored for drug discovery scientists.
What we did
Our design work contributed to VantAI's successful acquisition by Roivant Sciences in 2021.
Results
We met regularly with Roivant executives and their in-house SME (subject matter experts) who were computation chemists specializing in drug discovery. We led user interviews with VantAI's early customers to understand their needs and suggested a feature roadmap based on customer feedback. We ran a series of usability tests to ensure each new feature to the platform would be easy to understand and delightful to use.
